| cholinergic receptor, muscarinic 4 |
CHLORPROMAZINE |
Muscarinic M4 |
99% |
.149uM |
.021uM |
View
|
| cholinergic receptor, muscarinic 4 |
CLOTRIMAZOLE |
Muscarinic M4 |
99% |
11.756uM |
1.64uM |
View
|
| 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
LOVASTATIN |
HMG-CoA Reductase |
99% |
.02uM |
NoneNone |
View
|
| 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
LOVASTATIN |
HMG-CoA Reductase |
99% |
.02uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
AMIODARONE |
Calcium Channel Type L, Dihydropyridine |
99% |
.165uM |
.106uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
AMIODARONE |
Calcium Channel Type L, Dihydropyridine |
99% |
.165uM |
.106uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
AMIODARONE |
Calcium Channel Type L, Dihydropyridine |
99% |
.165uM |
.106uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
AMIODARONE |
Calcium Channel Type L, Dihydropyridine |
99% |
.165uM |
.106uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
AMIODARONE |
Calcium Channel Type L, Dihydropyridine |
99% |
.165uM |
.106uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Benzothiazepine |
99% |
1.403uM |
1.247uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Benzothiazepine |
99% |
1.403uM |
1.247uM |
View
|
| protein kinase D1 |
FAMOTIDINE |
Phorbol Ester |
3% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Benzothiazepine |
99% |
1.403uM |
1.247uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Benzothiazepine |
99% |
1.403uM |
1.247uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Benzothiazepine |
99% |
1.403uM |
1.247uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Benzothiazepine |
99% |
1.403uM |
1.247uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Benzothiazepine |
99% |
1.403uM |
1.247uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Benzothiazepine |
99% |
1.403uM |
1.247uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Benzothiazepine |
99% |
1.403uM |
1.247uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Benzothiazepine |
99% |
1.403uM |
1.247uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Benzothiazepine |
99% |
1.403uM |
1.247uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Benzothiazepine |
99% |
1.403uM |
1.247uM |
View
|
| A3 adenosine receptor |
CANDESARTAN |
Adenosine A3 |
99% |
1.2199uM |
.6895uM |
View
|
| prostaglandin-endoperoxide synthase 2 |
NIMESULIDE |
Cyclooxygenase COX-2 |
99% |
1.436uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
NIMESULIDE |
Cyclooxygenase COX-2 |
99% |
1.436uM |
NoneNone |
View
|
| dopamine receptor D3 |
ASTEMIZOLE |
Dopamine D3 |
99% |
.436uM |
.148uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
ASTEMIZOLE |
Serotonin Transporter |
99% |
1.318uM |
.7uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
ASTEMIZOLE |
Dopamine Transporter |
99% |
.998uM |
.793uM |
View
|
| Protein-tyrosine kinase, Fyn |
CLOMIPHENE |
Protein Tyrosine Kinase, Fyn |
99% |
2.513uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
CLOMIPHENE |
Adrenergic alpha2B |
99% |
1.578uM |
.721uM |
View
|
| epidermal growth factor receptor |
CADMIUM ACETATE |
Protein Tyrosine Kinase, EGF Receptor |
99% |
.244uM |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
CLOMIPHENE |
Serotonin Transporter |
99% |
.638uM |
.339uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
DROPERIDOL |
Serotonin 5-HT1A |
99% |
.242uM |
.138uM |
View
|
| adrenergic receptor, alpha 1a |
DOXAZOSIN |
Adrenergic alpha1A |
99% |
.001551uM |
.000628uM |
View
|
| adrenergic receptor, alpha 2b |
EMETINE |
Adrenergic alpha2C |
99% |
.182uM |
.026uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
EMETINE |
Adrenergic alpha2C |
99% |
.182uM |
.026uM |
View
|
| dopamine receptor D4 |
DISULFIRAM |
Dopamine D4.2 |
99% |
3.15uM |
1.105uM |
View
|
| cholinergic receptor, muscarinic 1 |
HOMATROPINE HYDROBROMIDE |
Muscarinic M1 |
99% |
.131uM |
.032uM |
View
|
| cholinergic receptor, muscarinic 4 |
HOMATROPINE HYDROBROMIDE |
Muscarinic M4 |
99% |
.101uM |
.014uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
ALOSETRON |
Serotonin 5-HT2B |
99% |
.1uM |
.064uM |
View
|
| chemokine (C-C motif) receptor 2 |
DISULFIRAM |
Chemokine CCR2B |
99% |
2.468uM |
.954uM |
View
|
| sodium channel, voltage-gated, type VIII, alpha polypeptide |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, voltage-gated, type XI, alpha |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, voltage-gated, type I, beta |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, voltage-gated, type 10, alpha polypeptide |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, voltage-gated, type IV, alpha polypeptide |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, voltage-gated, type V, alpha polypeptide |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, voltage-gated, type II, beta |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, nonvoltage-gated 1 gamma |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, nonvoltage-gated 1 beta |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, voltage-gated, type XI, alpha |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, nonvoltage-gated 1, gamma |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, nonvoltage-gated 1, delta |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, voltage-gated, type X, alpha |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, voltage-gated, type IX, alpha |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, voltage gated, type VIII, alpha |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| sodium channel, voltage-gated, type VII, alpha |
RITONAVIR |
Sodium Channel, Site 2 |
99% |
2.379uM |
2.133uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 5B |
DOXAZOSIN |
Serotonin 5-HT4 |
100% |
.764uM |
.127uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 4 |
DOXAZOSIN |
Serotonin 5-HT4 |
100% |
.764uM |
.127uM |
View
|
| adrenergic receptor, alpha 1a |
DROPERIDOL |
Adrenergic alpha1A |
100% |
.001653uM |
.000669uM |
View
|
| adrenergic receptor, alpha 2b |
DROPERIDOL |
Adrenergic alpha2B |
100% |
.22uM |
.101uM |
View
|
| adrenergic receptor, alpha 1b |
DOXAZOSIN |
Adrenergic alpha1B |
100% |
.000751uM |
.000416uM |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
GLIMEPIRIDE |
Potassium Channel [KATP] |
100% |
.1uM |
.011uM |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
GLIMEPIRIDE |
Potassium Channel [KATP] |
100% |
.1uM |
.011uM |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
GLIMEPIRIDE |
Potassium Channel [KATP] |
100% |
.1uM |
.011uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
CLOMIPHENE |
Adrenergic, Norepinephrine Transporter |
100% |
.862uM |
.855uM |
View
|
| progesterone receptor |
TIBOLONE |
Progesterone |
100% |
.2197uM |
.0287uM |
View
|
| progesterone receptor |
TIBOLONE |
Progesterone |
100% |
.2197uM |
.0287uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
VENLAFAXINE |
Serotonin Transporter |
100% |
.00718uM |
.003814uM |
View
|
| Protein-tyrosine kinase, Fyn |
ASTEMIZOLE |
Protein Tyrosine Kinase, Fyn |
100% |
2.847uM |
NoneNone |
View
|
| adrenergic receptor, alpha 1a |
ASTEMIZOLE |
Adrenergic alpha1A |
100% |
.024uM |
.009901uM |
View
|
| adrenergic receptor, alpha 1b |
ASTEMIZOLE |
Adrenergic alpha1B |
100% |
.172uM |
.095uM |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
ASTEMIZOLE |
Adrenergic alpha1D |
100% |
.769uM |
.378uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
ASTEMIZOLE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.305uM |
.296uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
ASTEMIZOLE |
Serotonin 5-HT2B |
100% |
.012uM |
.007487uM |
View
|
| estrogen receptor 1 |
CLOMIPHENE |
Estrogen ERalpha |
100% |
.004564uM |
.001304uM |
View
|
| estrogen receptor 1 |
CLOMIPHENE |
Estrogen ERalpha |
100% |
.004564uM |
.001304uM |
View
|
| adrenergic receptor, alpha 1a |
PIPAMAZINE |
Adrenergic alpha1A |
100% |
.005142uM |
.002081uM |
View
|
| dopamine receptor D3 |
PIPAMAZINE |
Dopamine D3 |
100% |
.004671uM |
.001586uM |
View
|
| adrenergic receptor, alpha 1b |
PIPAMAZINE |
Adrenergic alpha1B |
100% |
.00256uM |
.001417uM |
View
|
| cholinergic receptor, muscarinic 2 |
TRIHEXYPHENIDYL |
Muscarinic M2 |
100% |
.034uM |
.012uM |
View
|
| cholinergic receptor, muscarinic 3 |
TRIHEXYPHENIDYL |
Muscarinic M3 |
100% |
.015uM |
.003151uM |
View
|
| cholinergic receptor, muscarinic 4 |
TRIHEXYPHENIDYL |
Muscarinic M4 |
100% |
.005478uM |
.000764uM |
View
|
| dopamine receptor D3 |
HALOPROGIN |
Dopamine D3 |
100% |
.488uM |
.166uM |
View
|
| dopamine receptor D3 |
DISULFIRAM |
Dopamine D3 |
100% |
1.084uM |
.368uM |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
DOXAZOSIN |
Adrenergic alpha1D |
100% |
.003383uM |
.001663uM |
View
|
| sodium channel, voltage-gated, type IV, beta |
DOXAZOSIN |
Sodium Channel, Site 2 |
100% |
1.1uM |
1.003uM |
View
|
| sodium channel associated protein 1 |
DOXAZOSIN |
Sodium Channel, Site 2 |
100% |
1.1uM |
1.003uM |
View
|
| sodium channel associated protein 2 |
DOXAZOSIN |
Sodium Channel, Site 2 |
100% |
1.1uM |
1.003uM |
View
|
| sodium channel, voltage-gated, type III, beta |
DOXAZOSIN |
Sodium Channel, Site 2 |
100% |
1.1uM |
1.003uM |
View
|
| sodium channel, voltage-gated, type I, alpha |
DOXAZOSIN |
Sodium Channel, Site 2 |
100% |
1.1uM |
1.003uM |
View
|
| adrenergic receptor, alpha 2a |
OXYMETAZOLINE |
Adrenergic alpha2A |
98% |
.023uM |
.008639uM |
View
|
| cholinergic receptor, muscarinic 5 |
EBASTINE |
Muscarinic M5 |
98% |
.3378uM |
.2427uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
EBASTINE |
Serotonin 5-HT2C |
98% |
.2375uM |
.1244uM |
View
|
| Protein-tyrosine kinase, Fyn |
CADMIUM CHLORIDE |
Protein Tyrosine Kinase, Fyn |
98% |
.137uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
PHENYLHYDRAZINE |
Cyclooxygenase COX-2 |
98% |
1.514uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
PHENYLHYDRAZINE |
Cyclooxygenase COX-2 |
98% |
1.514uM |
NoneNone |
View
|
| adrenergic receptor, alpha 1b |
DAPIPRAZOLE |
Adrenergic alpha1B |
98% |
.055uM |
.03uM |
View
|
| adrenergic receptor, alpha 2a |
PHENTOLAMINE |
Imidazoline I2, Central |
98% |
.058uM |
.039uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
PHENTOLAMINE |
Imidazoline I2, Central |
98% |
.058uM |
.039uM |
View
|
| cholinergic receptor, muscarinic 4 |
BENZETHONIUM CHLORIDE |
Muscarinic M4 |
98% |
.257uM |
.036uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
BENZETHONIUM CHLORIDE |
Adrenergic, Norepinephrine Transporter |
98% |
.907uM |
.9uM |
View
|
| cholinergic receptor, muscarinic 1 |
BENZETHONIUM CHLORIDE |
Muscarinic M1 |
98% |
.412uM |
.099uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
RALOXIFENE |
Dopamine Transporter |
98% |
1.869uM |
1.485uM |
View
|
| mitogen activated protein kinase 14 |
SB-203580 |
Protein Serine/Threonine Kinase, p38alpha |
98% |
.159uM |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
SB-203580 |
Protein Serine/Threonine Kinase, p38alpha |
98% |
.159uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
TRIBROMSALAN |
Cyclooxygenase COX-1 |
98% |
2.065uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
TRIBROMSALAN |
Cyclooxygenase COX-1 |
98% |
2.065uM |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
ASTEMIZOLE |
Adrenergic, Norepinephrine Transporter |
98% |
1.375uM |
1.364uM |
View
|
| cholinergic receptor, muscarinic 4 |
ASTEMIZOLE |
Muscarinic M4 |
98% |
1.861uM |
.259uM |
View
|
| cholinergic receptor, muscarinic 1 |
ASTEMIZOLE |
Muscarinic M1 |
98% |
1.066uM |
.257uM |
View
|
| adrenergic receptor, alpha 2a |
CLOMIPHENE |
Adrenergic alpha2A |
98% |
.936uM |
.351uM |
View
|
| cholinergic receptor, muscarinic 3 |
ASTEMIZOLE |
Muscarinic M3 |
98% |
.84uM |
.178uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
CLONAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.004932uM |
.004018uM |
View
|
| gamma-aminobutyric acid A receptor, gamma 1 |
CLONAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.004932uM |
.004018uM |
View
|
| gamma-aminobutyric acid A receptor, pi |
CLONAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.004932uM |
.004018uM |
View
|
| AT hook, DNA binding motif, containing 1 (DBSS) |
CLONAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.004932uM |
.004018uM |
View
|
| gamma-aminobutyric acid A receptor, theta |
CLONAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.004932uM |
.004018uM |
View
|
| gamma-aminobutyric acid A receptor, gamma 2 |
CLONAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.004932uM |
.004018uM |
View
|
| protein kinase C, theta |
FAMOTIDINE |
Phorbol Ester |
3% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
CLONAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.004932uM |
.004018uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
CLONAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.004932uM |
.004018uM |
View
|
| gamma-aminobutyric acid A receptor, alpha 2 |
CLONAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.004932uM |
.004018uM |
View
|
| gamma-aminobutyric acid A receptor, alpha 1 |
CLONAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.004932uM |
.004018uM |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
CLONAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.004932uM |
.004018uM |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
CLONAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.004932uM |
.004018uM |
View
|
| gamma-aminobutyric acid A receptor, delta |
CLONAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.004932uM |
.004018uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
CLONAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.004932uM |
.004018uM |
View
|
| Protein-tyrosine kinase, Fyn |
CADMIUM ACETATE |
Protein Tyrosine Kinase, Fyn |
98% |
.197uM |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
DOXAZOSIN |
Dopamine Transporter |
98% |
.188uM |
.149uM |
View
|
| cholinergic receptor, muscarinic 5 |
DIPHENHYDRAMINE |
Muscarinic M5 |
98% |
.162uM |
.116uM |
View
|
| adrenergic receptor, alpha 2b |
HALOPROGIN |
Adrenergic alpha2C |
98% |
4.045uM |
.588uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
HALOPROGIN |
Adrenergic alpha2C |
98% |
4.045uM |
.588uM |
View
|
| histamine receptor H 1 |
DIPHENHYDRAMINE |
Histamine H1, Central |
98% |
.171uM |
.02uM |
View
|
| mitogen activated protein kinase 3 |
DISULFIRAM |
Protein Serine/Threonine Kinase, ERK1 |
98% |
1.51uM |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
DISULFIRAM |
Protein Serine/Threonine Kinase, ERK1 |
98% |
1.51uM |
NoneNone |
View
|
| cholinergic receptor, muscarinic 4 |
DIPHENHYDRAMINE |
Muscarinic M4 |
98% |
.372uM |
.052uM |
View
|
| gamma-aminobutyric acid A receptor, pi |
NITRAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0547uM |
.0446uM |
View
|
| AT hook, DNA binding motif, containing 1 (DBSS) |
NITRAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0547uM |
.0446uM |
View
|
| gamma-aminobutyric acid A receptor, theta |
NITRAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0547uM |
.0446uM |
View
|
| gamma-aminobutyric acid A receptor, gamma 2 |
NITRAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0547uM |
.0446uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
NITRAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0547uM |
.0446uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
NITRAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0547uM |
.0446uM |
View
|
| gamma-aminobutyric acid A receptor, alpha 2 |
NITRAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0547uM |
.0446uM |
View
|
| gamma-aminobutyric acid A receptor, alpha 1 |
NITRAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0547uM |
.0446uM |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
NITRAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0547uM |
.0446uM |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
NITRAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0547uM |
.0446uM |
View
|
| gamma-aminobutyric acid A receptor, delta |
NITRAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0547uM |
.0446uM |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
NITRAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0547uM |
.0446uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| protein kinase C, epsilon |
PACLITAXEL |
Phorbol Ester |
19% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
VERAPAMIL |
Calcium Channel Type L, Benzothiazepine |
98% |
.014uM |
.012uM |
View
|
| dopamine receptor 2 |
BROMOCRIPTINE |
Dopamine D2L |
98% |
.001582uM |
.000527uM |
View
|
| adrenergic receptor, alpha 2a |
GUANFACINE |
Adrenergic alpha2A |
98% |
.134uM |
.05uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
BROMOCRIPTINE |
Serotonin 5-HT2B |
98% |
.008316uM |
.005292uM |
View
|
| adrenergic receptor, alpha 2b |
MIANSERIN |
Adrenergic alpha2C |
98% |
.179uM |
.026uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
MIANSERIN |
Adrenergic alpha2C |
98% |
.179uM |
.026uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
MIANSERIN |
Adrenergic, Norepinephrine Transporter |
98% |
.163uM |
.161uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1B |
METHYSERGIDE |
Serotonin 5-HT1B |
98% |
.177uM |
.108uM |
View
|